ARASEC and Lead-in ADT - China focus

About this episode

The episode discusses the ARASEC trial and the ADT Lead-In study with a focus on findings relevant to mHSPC in China.

Two interesting papers caught the eye of our GU Cast China team this week; the first is the ARASEC trial which Dr Rana McKay read out in the Practice-Changing Plenary at the AUA Annual Meeting in Washington. This is an interesting comparison of ADT + darolutamide for mHSPC in a prospective US cohort, compared with an historical ADT-only control arm from CHAARTED. Interesting study design and interesting results. The second is the ADT Lead-In study led bu GU Cast China Editor, Dr Y...

People in this episode

Hosts: Professor Declan Murphy, Dr Renu Eapen

Topics covered

• ARASEC trial
• lead-in ADT
• mHSPC
• darolutamide
• clinical trials
• urology
• China

Keywords

• ARASEC trial
• lead-in ADT
• darolutamide
• mHSPC
• clinical trials
• urology
• China

Mentioned in this episode

Organizations: GU Cast China, AUA, CHAARTED

More episodes of GU Cast | Urology Podcast

• Bayer Apex comes to Melbourne! · June 9, 2026 · 26 min
• Did PROTEUS just change Urology?? · May 31, 2026 · 39 min
• Is Copper the new Gold??! Co-PSMA trial in European Urology · April 23, 2026 · 27 min
• EAU Prostate Cancer Guideline Update · April 12, 2026 · 29 min
• Journal club #7 | proPSMA and Penile Fractures(!) · April 6, 2026 · 28 min
• ASPIRE-ing to answer the Triplet question! With Rana McKay and Deepak Kilari · April 2, 2026 · 25 min